Wikipedia -WSS

Wikipedia

author：explore 2025-09-28 22:53:43 - browse：68385

health care AI border between health care and tech — Adobe

There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson.

The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech. And like the border between two nations, there are significant differences on either side.

During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Ebola vaccine can save some who are already sick, per new study

WSS

Congress considering partial increase for doctor pay in Medicare

Report cites 'urgent' need to recruit more diverse clinical trial participants

Fentanyl is making it harder to start addiction treatment

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Bernie Sanders gets little from pharma CEOs on drug prices

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Wikipedia

Wikipedia

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Abbott's new heart device gets FDA advisory panel nod

Medicare details structure of new drug price negotiation program

Congress must protect the remaining independent doctors

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why Eli Lilly’s earnings didn’t quite live up to the hype

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Virginia high school admissions case could be legal follow

Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

For longer

Liver decline slowed by off

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Long Covid research funding gets a major boost from NIH

H5N1 bird flu outbreak: Second human case reported, in Michigan

Juul documents reveal insider tactics on political lobbying

focus

hotspot

hotspot

knowledge